Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma
Mahrou Vahabi, Bilal Dehni, Inés Antomás, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 725-740
Open Access | Times Cited: 12

Showing 12 citing articles:

Immunotherapy: a promising approach for glioma treatment
Feroza Yasinjan, Xing Yang, Huayue Geng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 83
Dysregulation of a Subset of Circulating and Vesicle-Associated miRNA in Pancreatic Cancer
Giulia Girolimetti, Iulia Andreea Pelisenco, Leonardo Henry Eusebi, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 3, pp. 29-29
Open Access | Times Cited: 4
miR-301a-mediated crosstalk between the Hedgehog and HIPPO/YAP signaling pathways promotes pancreatic cancer
Bing Qi, Yuqiong Wang, Xian Zhu, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
miR‐135b‐5p/PDE3B Axis Regulates Gemcitabine Resistance in Pancreatic Cancer Through Epithelial‐Mesenchymal Transition
Yuxuan Fu, Liangsheng Chen, Ning Lv, et al.
Molecular Carcinogenesis (2025)
Closed Access
Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives
Belén Toledo, Chiara Deiana, Fabio Scianò, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 4, pp. 323-347
Open Access | Times Cited: 3
Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer
A.S. Pal, Anushka Ojha, Jingfang Ju
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17523-17523
Open Access | Times Cited: 6
Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer
Mahrou Vahabi, Geng Xu, Amir Avan, et al.
Nucleosides Nucleotides & Nucleic Acids (2024) Vol. 43, Iss. 8, pp. 837-850
Closed Access
A study on the correlation between microRNA and liver cirrhosis
Jianxu Yuan, Dalin Zhou, Sheng‐Jie Yu
Research Square (Research Square) (2024)
Open Access
Therapeutic Strategies in Advanced Cervical Cancer Detection, Prevention and Treatment
Xolisiwe M Sebutsoe, Nrateng Joyful Nonhlanzeko Tsotetsi, Zodwa E. Jantjies, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 785-801
Open Access
Small non-coding RNAs as diagnostic, prognostic and predictive biomarkers of gynecological cancers: an update
Marios A. Diamantopoulos, Panagiotis G. Adamopoulos, Andreas Scorilas
Expert Review of Molecular Diagnostics (2024), pp. 1-17
Closed Access
Machine learning-enhanced insights into sphingolipid-based prognostication: revealing the immunological landscape and predictive proficiency for immunomotherapy and chemotherapy responses in pancreatic carcinoma
Ting Shi, Minmin Li, Yabin Yu
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access
MicroRNA-218-5p accelerates malignant behaviors of breast cancer through LRIG1
Juhang Chu, Luyao Huang, Yaru Wang, et al.
Clinics (2023) Vol. 78, pp. 100302-100302
Open Access
Page 1

Scroll to top